ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 303

Predicting Chronic Pain in Children with Juvenile Idiopathic Arthritis: Results from the Childhood Arthritis Prospective Study

Amir Rashid1, Kate Holliday1, Lis Cordingley1, Roberto Carrasco1, Bo Fu2, Helen E. Foster3, Eileen Baildam4, Alice Chieng5, Joyce Davidson6, Lucy Wedderburn7, Kimme Hyrich8 and Wendy Thomson9, 1Centre for Musculoskeletal Research, Institute of Inflammation and Repair, The University of Manchester, Manchester, United Kingdom, 2Centre for Biostatistics, Institute of Population Health, The University of Manchester, Manchester, United Kingdom, 3Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom, 4Paediatric Rheumatology, Alder Hey Children's Foundation NHS Trust, Liverpool, United Kingdom, 5Paediatric Rheumatology, Royal Manchester Children's Hospital, Manchester, United Kingdom, 6Royal Hospital for Sick Children, Glasgow, United Kingdom, 7Rheumatology Unit , Institute of Child Health, University College London (UCL), London, United Kingdom, 8Arthritis Research UK Centre for Epidemiology, The University of Manchester, Manchester, United Kingdom, 9Institute of Inflammation and Repair, The University of Manchester, Manchester, United Kingdom

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: juvenile idiopathic arthritis (JIA), longitudinal studies and pain

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects: Juvenile Idiopathic Arthritis

Session Type: Abstract Submissions (ACR)

·         Background/Purpose: Pain is the most common symptom of JIA and has been associated with disease activity. However, disease activity has only accounted for a small amount of the variance in pain. This suggests predictors beyond clinical factors may be important in determining pain. The objectives of this study were to predict, at first presentation, children who are likely to have poor pain outcomes and how these children differ from those that improve.

·         Methods: Participants were children with new inflammatory arthritis who were recruited into the CAPS cohort and followed systematically with baseline data for the 100mm visual analogue scale (VAS) for pain available. A two-stage approach was used for the analysis. Firstly, pain trajectories were modelled in children with pain VAS at presentation and at one or more follow-up visits (up to five years post baseline) using a discrete mixture-model. Secondly, multinomial logistic regression was used to determine the association between baseline variables and trajectory groups (95%CI). These variables included the core outcome variables (active and limited joint counts, physician’s global assessment (PGA), parent/patient general evaluation (PGE), childhood HAQ (CHAQ) score), gender, age at onset and disease duration.

·         Results: 957 children were included. A three group trajectory model of pain was selected as the most clinically relevant model (Figure) and included a Low-Low pain group (trajectory 1), a High-Low pain group (trajectory 2) and a High-High pain group (trajectory 3). Children in the High-Low group and High-High group had significantly older age at onset, longer disease durations, more involved joints, higher PGE, PGA, pain and CHAQ scores at presentation, compared to children in the Low-Low group. Higher pain at baseline predicted membership of the High-High group (RRR 1.1 (95% CI 1.05, 1.1) and High-Low Pain (RRR 1.1 (95% CI 1.1, 1.1) compared to Low-Low group; and predicted membership in the High-Low group compared to the High-High group (RRR 0.98 (95% CI 0.97, 0.99). Both Higher CHAQ scores and older age at onset predicted membership in the High-High group compared to both the Low-Low group and the High-Low group. Longer disease duration at presentation predicted membership in the High-High group (RRR 1.03 (95% CI 1.01, 1.04) and the High-Low group (RRR 1.02 (95% CI 1.001, 1.03) compared to Low-Low group.

·         Conclusion: Even when adjusting for core outcome variables at presentation, participants who present earlier in their disease, are younger at disease onset and report less pain and functional problems upon presentation are less likely to report pain over time. Age at onset, functional problems and pain at presentation differentiated between high levels of pain which improved or persisted over time.

 


Disclosure:

A. Rashid,
None;

K. Holliday,
None;

L. Cordingley,
None;

R. Carrasco,
None;

B. Fu,
None;

H. E. Foster,

Pfizer Inc,

9,

Abbott Immunology Pharmaceuticals,

9,

Roche Pharmaceuticals,

9,

Novartis Pharmaceutical Corporation,

9;

E. Baildam,
None;

A. Chieng,
None;

J. Davidson,
None;

L. Wedderburn,
None;

K. Hyrich,
None;

W. Thomson,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/predicting-chronic-pain-in-children-with-juvenile-idiopathic-arthritis-results-from-the-childhood-arthritis-prospective-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology